Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Congreso Oncológico ecancer - Liga Colombiana contra el Cáncer /
Pathologic diagnosis of monoclonal gammopathy

17th - 18th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.01.17
Views: 1449

Dr Rocío Orduz - Organización Sanitas Internacional, Bogotá, Colombia

Dr Orduz speaks with ecancertv at the ecancer Colombian Cancer Congress about the process and prognosis of monoclonal gammopathies.

Monoclonal gammopathy of undetermined significance (MGUS) precedes myeloma proliferation, though only 1 in 100 cases develops into cancer, and Dr Orduz encourages vigilance in reaching an early diagnosis.

MGUS was discussed further by Dr Mateos at ICMM 2016.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation